Cargando…

Fluoroquinolone-resistant latent tuberculosis infection: A literature review and case series of 5 patients treated with linezolid monotherapy

Latent tuberculosis infection (LTBI) constitutes an important public health problem because of risk of progression to TB disease. Effective treatment of multi-drug resistant (MDR) LTBI would prevent progression to MDR TB disease, which would improve patient and public health outcomes. The majority o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baker, Jacob J., Nahar, Richa, Petroelje, Brian K., Goswami, Neela D., Lardizabal, Alfred A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10209533/ https://www.ncbi.nlm.nih.gov/pubmed/37252368 http://dx.doi.org/10.1016/j.jctube.2023.100376

Ejemplares similares

Notes from the Field: Acquisition of Delamanid Under a Compassionate Use Program for Extensively Drug-Resistant Tuberculosis — United States, 2017
por: Lardizabal, Alfred A., et al.
Publicado: (2018)

Fluoroquinolones for the treatment of latent Mycobacterium tuberculosis infection in liver transplantation
por: Silva, Jose Tiago, et al.
Publicado: (2019)

Linezolid use for the treatment of multidrug-resistant tuberculosis, TB centers of excellence, United States, 2013–2018
por: McDowell, Ashley, et al.
Publicado: (2020)

Low Rate of Acquired Linezolid Resistance in Multidrug-Resistant Tuberculosis Treated With Bedaquiline-Linezolid Combination
por: Du, Jian, et al.
Publicado: (2021)

Linezolid for Treating Tuberculosis: A Delicate Balancing Act
por: Maartens, Gary, et al.
Publicado: (2015)

Four months of rifampicin monotherapy for latent tuberculosis infection in children
por: Oh, Chi Eun, et al.
Publicado: (2021)

Single-Cell Cytokine Gene Expression in Peripheral Blood Cells Correlates with Latent Tuberculosis Status
por: Vir, Pooja, et al.
Publicado: (2015)

Linezolid for drug‐resistant pulmonary tuberculosis
por: Singh, Bhagteshwar, et al.
Publicado: (2019)

Anemia with elevation of growth differentiation factor-15 level in linezolid treated multidrug-resistant tuberculosis: Case series of three patients
por: Oehadian, Amaylia, et al.
Publicado: (2022)

1400. Pretomanid in the Treatment of Patients with Tuberculosis in the United States: the Bedaquiline, Pretomanid and Linezolid (BPaL) Accelerated Monitoring (BAM) Project
por: Goswami, Neela, et al.
Publicado: (2021)

Linezolid-resistant Mycobacterium tuberculosis: Will it impact the tuberculosis elimination programme?
por: Bharadwaj, Renu
Publicado: (2021)

The Role of Fluoroquinolones in the Treatment of Tuberculosis in 2019
por: Pranger, A. D., et al.
Publicado: (2019)

Linezolid for Infants and Toddlers With Disseminated Tuberculosis: First Steps
por: Deshpande, Devyani, et al.
Publicado: (2016)

Peripheral neuropathy in a diabetic child treated with linezolid for multidrug-resistant tuberculosis: a case report and review of the literature
por: Swaminathan, Aravind, et al.
Publicado: (2017)

The uncertainty, challenges, and variability in tuberculosis congregate setting investigations: The concentric circle model revisited
por: Wolman, Mark, et al.
Publicado: (2018)

Fluoroquinolone resistant tuberculosis: A case report and literature review
por: Gill, Ajaypal, et al.
Publicado: (2019)

Predictors of latent tuberculosis treatment initiation and completion at a U.S. public health clinic: a prospective cohort study
por: Goswami, Neela D, et al.
Publicado: (2012)

Linezolid induced optic neuropathy in a child treated for extensively drug resistant tuberculosis: A case report and review of literature
por: Agashe, Prachi, et al.
Publicado: (2019)

Patterns of Fluoroquinolone Prescribing at a Tuberculosis Hospital
por: Kizilbash, Quratulain, et al.
Publicado: (2017)

Fluoroquinolone resistance in multidrug-resistant tuberculosis patients
por: Lee, Hyun-Woo, et al.
Publicado: (2019)

Fluoroquinolone Derivatives in the Treatment of Mycobacterium tuberculosis Infection
por: Pais, João Pedro, et al.
Publicado: (2022)

Preclinical Evaluations To Identify Optimal Linezolid Regimens for Tuberculosis Therapy
por: Brown, Ashley N., et al.
Publicado: (2015)

Bedaquiline and Linezolid for Extensively Drug-Resistant Tuberculosis in Pregnant Woman
por: Jaspard, Marie, et al.
Publicado: (2017)

Pharmacodynamic Correlates of Linezolid Activity and Toxicity in Murine Models of Tuberculosis
por: Bigelow, Kristina M, et al.
Publicado: (2020)

Low-Dose Linezolid for Treatment of Patients With Multidrug-Resistant Tuberculosis
por: Mase, Anjeli, et al.
Publicado: (2022)

Use of Isoniazid Monotherapy in Comparison to Rifamycin-Based Regimen for the Treatment of Patients With Latent Tuberculosis: A Systematic Review
por: Shahid, Noor ul ain, et al.
Publicado: (2022)

Evaluation of IL-1 Blockade as an Adjunct to Linezolid Therapy for Tuberculosis in Mice and Macaques
por: Winchell, Caylin G., et al.
Publicado: (2020)

Beta-Lactam vs. Fluoroquinolone Monotherapy for Pseudomonas aeruginosa Infection: A Systematic Review and Meta-Analysis
por: Reid, Eric, et al.
Publicado: (2021)

Linezolid-Induced Pancytopenia in Patients Using Dapagliflozin: A Case Series
por: Li, Meng Mei, et al.
Publicado: (2022)

Does empirical treatment of community-acquired pneumonia with fluoroquinolones delay tuberculosis treatment and result in fluoroquinolone resistance in Mycobacterium tuberculosis? Controversies and solutions
por: Shen, Gwan-Han, et al.
Publicado: (2012)

Ertapenem for treatment of osteomyelitis: a case series
por: Goswami, Neela D, et al.
Publicado: (2011)

The Negative Clinical Impact of Diabetes on Tuberculosis: A Cross-Sectional Study in New Jersey
por: Kreisel, Charles F, et al.
Publicado: (2018)

Changes in chest CT findings of pulmonary tuberculosis after linezolid treatment
por: Kim, Sanghyeon, et al.
Publicado: (2013)

Graphene Oxide-Linezolid Combination as Potential New Anti-Tuberculosis Treatment
por: De Maio, Flavio, et al.
Publicado: (2020)

Model-Informed Precision Dosing of Linezolid in Patients with Drug-Resistant Tuberculosis
por: Mockeliunas, Laurynas, et al.
Publicado: (2022)

Linezolid-Associated Neuropathy in Patients with MDR/XDR Tuberculosis in Shenzhen, China
por: Zhang, Peize, et al.
Publicado: (2022)

Mechanism underlying linezolid-induced peripheral neuropathy in multidrug-resistant tuberculosis
por: Yuan, Yuan, et al.
Publicado: (2022)

Population pharmacokinetics and dose evaluations of linezolid in the treatment of multidrug-resistant tuberculosis
por: Zhang, Haoyue, et al.
Publicado: (2023)

Fluoroquinolone-Resistant Mycobacterium tuberculosis, Pakistan, 2005–2009
por: Jabeen, Kauser, et al.
Publicado: (2011)

The Use of Fluoroquinolones for Tuberculosis in Victoria between 2011 and 2016
por: Murray, Hugh, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_2bfh5s33ne8l2vtnqtjfjdi2ud